Northern India Herald

Spine Pain Market to Exhibit Moderate Growth Rate till (2022-2032), Investigates DelveInsight | Key Companies – Novartis, Regeneron Pharmaceuticals, Stayble Therapeutics

 Breaking News
  • No posts were found

Spine Pain Market to Exhibit Moderate Growth Rate till (2022-2032), Investigates DelveInsight | Key Companies – Novartis, Regeneron Pharmaceuticals, Stayble Therapeutics

January 19
21:33 2023
Spine Pain Market to Exhibit Moderate Growth Rate till (2022-2032), Investigates DelveInsight | Key Companies - Novartis, Regeneron Pharmaceuticals, Stayble Therapeutics
The Spine Pain market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Spine Pain pipeline products will significantly revolutionize the Spine Pain market dynamics.

DelveInsight’s “Spine Pain Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Spine Pain, historical and forecasted epidemiology as well as the Spine Pain market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


The Spine Pain market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 


To Know in detail about the Spine Pain market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Spine Pain Market Insights


Spine Pain Overview

Pain arising from various structures of the spine constitutes the majority of the problems in chronic pain settings. Spine pain is generally of two types: the lumbar region (lower back) and cervical region (neck). Lumbar muscle strains and sprains are the most common causes of low back pain. The thoracic spine can also be a site of spinal pain, but because it is much more rigid, the thoracic spinal area is much less frequently injured than the lumbar and cervical spine. The lifetime prevalence of spinal pain has been reported as 54% to 80%.


Some of the key facts of the Spine Pain Market Report: 

  • The Spine Pain market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
  • Back pain is widespread in the adult population. Some studies have shown that up to 23% of the world’s adults suffer from chronic low back pain
  • As per review study by Kazeminasab et al., neck pain is one of the most common musculoskeletal disorders, having an age-standardised prevalence rate of 27.0 per 1000 population
  • According to Manchikanti et al., the annual prevalence estimates of any neck pain among adults ranged from 12.1% to 71.5% and among children, it ranged from 34.5% to 71.5%, with most estimates of annual prevalence between 30% and 50%
  • Key Spine Pain Companies: Novartis, Regeneron Pharmaceuticals, Stayble Therapeutics, and others
  • Key Spine Pain Therapies: AIN457, Fasinumab (REGN475), STA363, and others


Get a Free sample for the Spine Pain Market Report –


Key benefits of the Spine Pain Market report:

  1. Spine Pain market report covers a descriptive overview and comprehensive insight of the Spine Pain Epidemiology and Spine Pain market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Spine Pain market report provides insights on the current and emerging therapies.
  3. Spine Pain market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Spine Pain market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Spine Pain market.


Download the report to understand which factors are driving Spine Pain epidemiology trends @ Spine Pain Epidemiological Insights 


Spine Pain Market  

The dynamics of the Spine Pain market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032. 

“The lack of information about treatments by chiropractors, physical therapists, and other care providers results in underestimated cost estimates for treatment of low back pain.”


Spine Pain Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.


Spine Pain Epidemiology Segmentation:

The Spine Pain market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Spine Pain
  • Prevalent Cases of Spine Pain by severity
  • Gender-specific Prevalence of Spine Pain
  • Diagnosed Cases of Episodic and Chronic Spine Pain


Spine Pain Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Spine Pain market or expected to get launched during the study period. The analysis covers Spine Pain market uptake by drugs, patient uptake by therapies, and sales of each drug.  

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Spine Pain Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.


Discover more about therapies set to grab major Spine Pain market share @ Spine Pain market forecast 


Spine Pain Therapies and Key Companies

  • AIN457: Novartis
  • Fasinumab (REGN475): Regeneron Pharmaceuticals
  • STA363: Stayble Therapeutics


Scope of the Spine Pain Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Spine Pain Companies: Novartis, Regeneron Pharmaceuticals, Stayble Therapeutics, and others
  • Key Spine Pain Therapies: AIN457, Fasinumab (REGN475), STA363, and others
  • Spine Pain Therapeutic Assessment: Spine Pain current marketed and Spine Pain emerging therapies
  • Spine Pain Market Dynamics: Spine Pain market drivers and Spine Pain market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Spine Pain Unmet Needs, KOL’s views, Analyst’s views, Spine Pain Market Access and Reimbursement 


Spine Pain Market Unmet Needs

  • Challenges in diagnosis
  • Development of novel therapies
  • No approved therapies
  • Poor disease understanding
  • Clinical biomarkers 


Table of Contents 

1. Spine Pain Market Report Introduction

2. Executive Summary for Spine Pain

3. SWOT analysis of Spine Pain

4. Spine Pain Patient Share (%) Overview at a Glance

5. Spine Pain Market Overview at a Glance

6. Spine Pain Disease Background and Overview

7. Spine Pain Epidemiology and Patient Population

8. Country-Specific Patient Population of Spine Pain 

9. Spine Pain Current Treatment and Medical Practices

10. Spine Pain Unmet Needs

11. Spine Pain Emerging Therapies

12. Spine Pain Market Outlook

13. Country-Wise Spine Pain Market Analysis (2019–2032)

14. Spine Pain Market Access and Reimbursement of Therapies

15. Spine Pain Market Drivers

16. Spine Pain Market Barriers

17.  Spine Pain Appendix

18. Spine Pain Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight


To know more about Spine Pain treatment, visit @ Spine Pain Medications  

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States